Social determinants of visceral leishmaniasis elimination in Eastern Africa
© World Health Organization 2023. Licensee BMJ..
Visceral leishmaniasis is a vector-borne, protozoan disease with severe public health implications. Following the successful implementation of an elimination programme in South Asia, there is now a concerted endeavour to replicate these efforts in Eastern Africa based on the five essential elimination pillars of case management, integrated vector management, effective surveillance, social mobilisation and operational research. This article highlights how key social determinants (SD) of health (poverty, sociocultural factors and gender, housing and clustering, migration and the healthcare system) operate at five different levels (socioeconomic context and position, differential exposure, differential vulnerability, differential outcomes and differential consequences). These SD should be considered within the context of increasing the success of the five-pillar elimination programme and reducing inequity in health.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
BMJ global health - 8(2023), 6 vom: 28. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alvar, Jorge [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Control strategies |
|---|
| Anmerkungen: |
Date Completed 30.06.2023 Date Revised 03.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjgh-2023-012638 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358816572 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358816572 | ||
| 003 | DE-627 | ||
| 005 | 20231226075541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjgh-2023-012638 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1196.xml |
| 035 | |a (DE-627)NLM358816572 | ||
| 035 | |a (NLM)37380365 | ||
| 035 | |a (PII)e012638 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alvar, Jorge |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Social determinants of visceral leishmaniasis elimination in Eastern Africa |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.06.2023 | ||
| 500 | |a Date Revised 03.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © World Health Organization 2023. Licensee BMJ. | ||
| 520 | |a Visceral leishmaniasis is a vector-borne, protozoan disease with severe public health implications. Following the successful implementation of an elimination programme in South Asia, there is now a concerted endeavour to replicate these efforts in Eastern Africa based on the five essential elimination pillars of case management, integrated vector management, effective surveillance, social mobilisation and operational research. This article highlights how key social determinants (SD) of health (poverty, sociocultural factors and gender, housing and clustering, migration and the healthcare system) operate at five different levels (socioeconomic context and position, differential exposure, differential vulnerability, differential outcomes and differential consequences). These SD should be considered within the context of increasing the success of the five-pillar elimination programme and reducing inequity in health | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Control strategies | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Public Health | |
| 650 | 4 | |a Treatment | |
| 650 | 4 | |a Visceral leishmaniasis | |
| 700 | 1 | |a Beca-Martínez, Maria Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Argaw, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Jain, Saurabh |e verfasserin |4 aut | |
| 700 | 1 | |a Aagaard-Hansen, Jens |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ global health |d 2016 |g 8(2023), 6 vom: 28. Juni |w (DE-627)NLM262254549 |x 2059-7908 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:6 |g day:28 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjgh-2023-012638 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 6 |b 28 |c 06 | ||